Adults 11 to 20, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Proportion at Risk for Cigarette SmokingPrimary· within 5 minutes of the intervention
A two item self-report assessment: 1) If one of your best friends offered you an unflavored cigarette would you use it? 2) If one of your best friends offered you a menthol cigarette would you use it? Responses to each item are made on a 10-point scale where 1 = definitely not; and 10 = definitely yes and responses across the two items are summed for a total scale score. Total scale scores are dichotomized: scores of 2 are coded as '0' (no risk) and any score greater than 2 is coded as '1' (at risk). Outcome is proportion at risk of cigarette smoking (number of participants at risk over number
Group
Value
95% CI
Control
.18
.11 – .29
Small
.39
.27 – .53
Medium
.26
.16 – .38
Proportion at Risk of Using Electronic Nicotine Delivery Devices (ENDS)Primary· within 5 minutes of the intervention
A three item, self-report assessment: 1) If one of your best friends offered you an unflavored vaping product would you use it? 2) If one of your best friends offered you a vaping product flavored with menthol or mint, would you use it? 3) If one of your best friends offered you a vaping product flavored with fruit, candy, alcohol or non-alcohol drink, or some other sweet flavor, would you use it? Responses to each item are made on a 10-point scale where 1 = definitely not; and 10 = definitely yes and responses across the three items are summed for a total scale score. Total scale scores are d
Group
Value
95% CI
Control
.34
.22 – .47
Small
.59
.46 – .72
Medium
.59
.45 – .72
Proportion at Risk of Using Smokeless TobaccoPrimary· within 5 minutes of the intervention
A three item self report assessment: : 1) If one of your best friends offered you unflavored smokeless tobacco would you use it? 2) If one of your best friends offered you smokeless tobacco flavored with flavored with menthol, mint, spearmint, or wintergreen would you use it? 3) If one of your best friends offered you smokeless tobacco flavored with fruit would you use it? Responses to each item are made on a 10-point scale where 1 = definitely not; and 10 = definitely yes and responses across the three items are summed for a total scale score. Total scale scores are dichotomized: scores of 3
Group
Value
95% CI
Control
.12
.06 – .21
Small
.20
.12 – .31
Medium
.17
.10 – .27
Proportion at Risk of Using Little Cigar/Cigarillos (LCC)Primary· within 5 minutes of the intervention
A three item, self report assessment: 1) If one of your best friends offered you an unflavored cigarillos/filtered cigar would you use it? 2) If one of your best friends offered you a cigarillos/filtered cigar flavored with menthol or mint would you use it? 3) If one of your best friends offered you a cigarillos/filtered cigar flavored with fruit, candy, alcohol, or some other sweet flavor, would you use it? Responses to each item are made on a 10-point scale where 1 = definitely not; and 10 = definitely yes and responses across the three items are summed for a total scale score. Total scale s
Group
Value
95% CI
Control
.17
.10 – .27
Small
.31
.20 – .44
Medium
.20
.12 – .32
Sponsor's own description
The overall aim of this research is to experimentally evaluate the extent to which reducing the size of the tobacco power wall and the number of tobacco product units displayed influences tobacco use risk in adolescents.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07162935 — Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
· NA
· recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products
· NA
· recruiting
NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
· Phase 4
· recruiting
NCT06983678 — Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron
· NA
· recruiting
NCT06922617 — STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
· NA
· recruiting
Other RAND trials
Trials by the same sponsor.
NCT06048328 — Game Changers for Family Planning Peer Advocacy Program
· Phase 1, PHASE2
· not yet recruiting
NCT07072819 — Pilot of Training on 988 and Narcan
· NA
· completed
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
· NA
· recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
· NA
· recruiting
NCT06827288 — Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RAND
Last refreshed: 25 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04632030.